Moritz Ammelburg, Ph.D., helps innovators craft, secure, and defend broad, robust, and commercially meaningful patents that will help treat patients in the future.
A talented lawyer and imaginative life scientist with a doctorate in biochemistry, Moritz clearly understands his clients’ innovations and how best to protect them. He excels in patent prosecution, patent portfolio management, and post-grant proceedings involving innovations across the life sciences, biotech, diagnostic, and pharmaceutical sectors.
In advising clients, Moritz looks to the future, anticipating challenges, changes, risks, and opportunities. Diligent and hardworking, he delves into the details of each invention to build strong and effective patents. When taking on a case, he studies the history, science, and law, listens to and learns from his clients, and then determines the best path forward to achieve the client's goals.
When third parties challenge a client's patent, Moritz is well prepared to defend that client's rights before the European Patent Office. His confident, clear, and compelling arguments grounded in the facts have resulted in resounding victories for his clients in EPO opposition proceedings against industry-leading companies, including Merck, Pfizer, and Roche Diagnostics.
Moritz chose a legal career to help protect and bring medical innovations to market to improve the lives of patients worldwide. He thrives on learning about innovations in his field and loves the challenge of working with knowledgeable and creative innovators.
In addition to maintaining a dynamic legal practice, Moritz heads the Life Sciences Group of the firm’s Munich office, which he grew from a one-person operation to a thriving group. As a group leader, he mentors technology specialists and associates, contributing to the firm’s solid pipeline of skilled, up-and-coming talent.
In his spare time, Moritz enjoys going out for a run with his son even though the boy is already the faster runner.
Merck Sharp & Dohme Corp. and Neuefeind, Regina v. Mayo Foundation for Medical Education and Research – Represented Mayo Foundation in EPO opposition-appeal proceedings and defended European patent EP1234031. Patent was maintained including claim covering EMA approved therapeutic antibodies.
Pfizer Inc. and Merck Patent GmbH v. Mayo Foundation for Medical Education and Research – Represented Mayo Foundation in EPO opposition proceedings and defended European patent EP3052131. Patent was maintained as granted.
Ammelburg, Moritz v. Bruschettini S.r.l. – Represented Opponent in EPO opposition proceedings and challenged European patent EP3016654. Patent was revoked in its entirety in first instance.
James Poole Limited v. Massachusetts Eye & Ear Infirmary – Represented Massachusetts Eye & Ear Infirmary in EPO opposition proceedings and defended European patent EP2381936. Patent was maintained and protection of the clinical embodiments was secured.
Ammelburg, Moritz v. Roche Diagnostics GmbH and F. Hoffmann-La Roche AG – Represented Opponent in EPO opposition proceedings and challenged European patent EP3213085. Patent was maintained in significantly limited form.
Recognitions & awards
Max Planck Society
German National Academic Foundation
German Chemical Industry Fund
Institute of Professional Representatives before the European Patent Office